• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

艰难梭菌感染患者粪菌移植(FMT)过程中肠道微生物组的演变:不同软件程序的 NGS 分析。

Evolution of intestinal microbiome in a process of faecal microbiota transfer (FMT) in a patient with Clostridioides difficile infection: NGS analysis with different software programs.

机构信息

Servicio de Microbiología. Hospital General Universitario de Alicante. Instituto de Investigación Sanitaria y Biomédica de Alicante-ISABIAL, Alicante, España.

Servicio de Microbiología. Hospital General Universitario de Alicante. Instituto de Investigación Sanitaria y Biomédica de Alicante-ISABIAL, Alicante, España.

出版信息

Enferm Infecc Microbiol Clin (Engl Ed). 2021 Apr;39(4):184-187. doi: 10.1016/j.eimc.2020.05.023. Epub 2020 Jul 15.

DOI:10.1016/j.eimc.2020.05.023
PMID:32680797
Abstract

INTRODUCTION

Clostridioides difficile infection (CDI) has become a global healthcare challenge due to increases in its incidence and mortality rates. Faecal microbiota transfer (FMT) is postulated as a protocol to prevent CDI recurrence.

MATERIAL AND METHODS

A donor faecal sample and patient faecal samples (pre-FMT and post-FMT) were analysed. The r16S gene was amplified and sequenced by NGS, and its diversity and taxonomy composition were examined.

RESULTS

Microbial richness increased in post-FMT samples, and the β diversity studies grouped the samples into two clusters. One included the non-pathological samples (donor and pre-FMT samples), and the other included the pathological sample. The results obtained by Qiime2 and Bioconductor were similar.

CONCLUSION

The analysis showed an increase in taxonomic diversity after the FMT, which suggests its usefulness. Moreover, these results showed that standardisation of bioinformatics analysis is key.

摘要

简介

由于艰难梭菌感染(CDI)的发病率和死亡率不断上升,它已成为全球医疗保健的挑战。粪便微生物群转移(FMT)被认为是预防 CDI 复发的方案。

材料与方法

分析供体粪便样本和患者粪便样本(FMT 前和 FMT 后)。通过 NGS 扩增和测序 r16S 基因,并检查其多样性和分类组成。

结果

FMT 后样本中的微生物丰富度增加,β多样性研究将样本分为两个聚类。一个聚类包括非病理性样本(供体和 FMT 前样本),另一个聚类包括病理性样本。Qiime2 和 Bioconductor 得到的结果相似。

结论

分析表明 FMT 后分类多样性增加,提示其有用性。此外,这些结果表明生物信息学分析的标准化是关键。

相似文献

1
Evolution of intestinal microbiome in a process of faecal microbiota transfer (FMT) in a patient with Clostridioides difficile infection: NGS analysis with different software programs.艰难梭菌感染患者粪菌移植(FMT)过程中肠道微生物组的演变:不同软件程序的 NGS 分析。
Enferm Infecc Microbiol Clin (Engl Ed). 2021 Apr;39(4):184-187. doi: 10.1016/j.eimc.2020.05.023. Epub 2020 Jul 15.
2
Faecal microbiota transplantation in the treatment of recurrent intestinal Clostridioides difficile infection - a ten-year single-center experience.粪便微生物群移植治疗复发性肠道艰难梭菌感染 - 十年单中心经验。
Cas Lek Cesk. 2022 Summer;161(3-4):126-130.
3
Efficacy of lyophilised bacteria-rich faecal sediment and supernatant with reduced bacterial count for treating patients with Infection - A novel method for capsule faecal microbiota transfer.富含细菌的冻干粪便沉淀物和上清液(细菌计数减少)治疗感染患者的疗效-胶囊粪便微生物群转移的新方法。
Front Cell Infect Microbiol. 2023 Jan 23;13:1041384. doi: 10.3389/fcimb.2023.1041384. eCollection 2023.
4
Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent infection.微生物胆汁盐水解酶介导粪菌移植治疗复发性感染的疗效。
Gut. 2019 Oct;68(10):1791-1800. doi: 10.1136/gutjnl-2018-317842. Epub 2019 Feb 11.
5
Factors Related to Outcomes of Fecal Microbiota Transplantation in Patients with Infection.与感染患者粪便微生物群移植结局相关的因素。
Gut Liver. 2021 Jan 15;15(1):61-69. doi: 10.5009/gnl20135.
6
Longitudinal Bile Acid Composition Changes Following Faecal Microbiota Transplantation for Clostridioides difficile Infection in Children With and Without Underlying Inflammatory Bowel Disease.儿童艰难梭菌感染行粪菌移植后胆汁酸组成的纵向变化:有无炎症性肠病的比较。
J Crohns Colitis. 2023 Aug 21;17(8):1364-1368. doi: 10.1093/ecco-jcc/jjad057.
7
Faecal microbiota transplantation for recurrent Clostridioides difficile infection: an Australian experience - effective, safe, yet room for improvement.粪便微生物群移植治疗复发性艰难梭菌感染:澳大利亚的经验——有效、安全,但仍有改进空间。
Intern Med J. 2021 Jan;51(1):106-110. doi: 10.1111/imj.15162.
8
Functional profile of host microbiome indicates infection.宿主微生物组的功能特征表明存在感染。
Gut Microbes. 2022 Jan-Dec;14(1):2135963. doi: 10.1080/19490976.2022.2135963.
9
Fecal microbiota transplantation as therapy for recurrent Clostridioides difficile infection is associated with amelioration of delirium and accompanied by changes in fecal microbiota and the metabolome.粪便微生物群移植作为复发性艰难梭菌感染的治疗方法与谵妄的改善相关,并伴有粪便微生物群和代谢组的变化。
Anaerobe. 2022 Feb;73:102502. doi: 10.1016/j.anaerobe.2021.102502. Epub 2021 Dec 9.
10
Fecal Microbiota Transplantation Increases Colonic IL-25 and Dampens Tissue Inflammation in Patients with Recurrent Clostridioides difficile.粪便微生物移植增加复发性艰难梭菌患者结肠中的 IL-25 并抑制组织炎症。
mSphere. 2021 Oct 27;6(5):e0066921. doi: 10.1128/mSphere.00669-21.

引用本文的文献

1
A comprehensive R package for deep mining microbiome.一个用于深度挖掘微生物组的综合R包。
Innovation (Camb). 2023 Feb 2;4(2):100388. doi: 10.1016/j.xinn.2023.100388. eCollection 2023 Mar 13.